EDWARD SATHOFF: Open Payments
NPI 1093794950 · MANKATO, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 17 payments from 11 companies in 2025. Trend: 2023 $183 · 2024 $407 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 5 | $102 |
| HARMONY BIOSCIENCES LLC | 1 | $34 |
| Soleno Therapeutics, Inc. | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Neuronetics, Inc. | 1 | $25 |
| Indivior Inc. | 1 | $18 |
| ACADIA Pharmaceuticals Inc | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| JAZZ PHARMACEUTICALS INC. | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
Products named: Qelbree, WAKIX, VYKAT XR, AUSTEDO XR, NEUROSTAR TMS THERAPY SYSTEM, SUBLOCADE, NUPLAZID, FANAPT.
Industry payments across MN — which companies pay providers there.
